How long does Survodutide take to work?
In the first week of Survodutide, appetite drops. Mild nausea. Slight body-temp uptick (glucagon thermogenesis). Around week 4, first titration step. ~3-6 lb down for most users. By week 8, cumulative loss building steadily. Phase 3 topline was ~16.6% at 76 weeks, below Retatrutide but well above GLP-1-only options. Response varies between people, this is the commonly reported pattern, not a guarantee.
Week by week
- Week 1: Appetite drops. Mild nausea. Slight body-temp uptick (glucagon thermogenesis).
- Week 4: First titration step. ~3-6 lb down for most users.
- Week 8: Cumulative loss building steadily. Phase 3 topline was ~16.6% at 76 weeks, below Retatrutide but well above GLP-1-only options.
References
- Survodutide for treatment of obesity, Phase 2 trial — le Roux CW et al., Lancet Diabetes Endocrinol, 2024
- A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis — Sanyal et al., N Engl J Med, 2024
Pepdex is an editorial reference, not medical advice. Peptides vary in legal and approval status by country, many are research compounds without full human safety data. Talk to a qualified clinician before starting anything.
More on Survodutide
Last updated 2026-06-06.